The safety and efficacy of the endoscopic tissue shielding method with polyglycolic acid sheets for wounds after endoscopic submucosal dissectio
Phase 2
- Conditions
- gastrointestinal neoplasms to be resected by endoscopic submucosal dissection (ESD)
- Registration Number
- JPRN-UMIN000011058
- Lead Sponsor
- the Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1. Those who fall under the category of contraindication of Neoveil or Beriplast. Neoveil: those who have systematic complications Beriplast: 1) those who have a history of anaphylaxis to components of Beriplast or drugs made of bovine lung, such as aprotinin 2) those who are treated with procoagulants (hemocoagulase made from snake venom), antifibrolytic agents, and aprotinin 2. Those who are considered to be inappropriate for this study by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method